Thromb Haemost 1999; 81(06): 994-995
DOI: 10.1055/s-0037-1614616
Letters to the Editor
Schattauer GmbH

Which Assay Is the Most Suitable to Investigate von Willebrand Factor Functional Activity ?

A. Casonato
1   From the University of Padua Medical School, Institute of Medical Semeiotics and Second Chair of Internal Medicine, Padua, Italy
,
E. Pontara
1   From the University of Padua Medical School, Institute of Medical Semeiotics and Second Chair of Internal Medicine, Padua, Italy
,
A. Bertomoro
1   From the University of Padua Medical School, Institute of Medical Semeiotics and Second Chair of Internal Medicine, Padua, Italy
,
F. Sartorello
1   From the University of Padua Medical School, Institute of Medical Semeiotics and Second Chair of Internal Medicine, Padua, Italy
,
A. Girolami
1   From the University of Padua Medical School, Institute of Medical Semeiotics and Second Chair of Internal Medicine, Padua, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 21. Dezember 1998

Accepted 10. März 1999

Publikationsdatum:
09. Dezember 2017 (online)

 

 
  • References

  • 1 Preston FE. Assays for von Willebrand factor functional activity: a UK NEQAS survey. Thromb Haemost 1998; 80: 863.
  • 2 Murdock PJ, Woodhams BJ, Matthews KB, Pasi J, Goodhall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic procedure use. Thromb Haemost 1997; 78: 1272-7.
  • 3 Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
  • 4 Casonato A, Pontara E, Bertomoro A, Zucchetto S, Zerbinati P, Girolami A. Abnormal collagen binding activity of 2A von Willebrand factor: Evidence that the defect depends only on the lack of large multimers. J Lab Clin Med 1997; 129: 251-9.